Rabbit Coccidiosis Study Guide

Overview and Clinical Importance

Coccidiosis is a highly significant parasitic disease caused by protozoan parasites of the genus Eimeria. It represents one of the most important health challenges in rabbits worldwide, affecting both commercial operations and pet rabbits. The disease can be subclinical or cause devastating mortality, particularly in young, recently weaned rabbits. Eleven species of Eimeria have been identified in domestic rabbits, with varying pathogenicity. Coccidiosis is classified into two forms: hepatic coccidiosis (caused by Eimeria stiedae) and intestinal coccidiosis (caused by 10 other species).

It is critical to distinguish between infection (presence of coccidia, which is common) and coccidiosis (overt disease, which is less frequent but serious). Many healthy adult rabbits can carry coccidia and shed oocysts without developing clinical signs, yet they can serve as reservoirs and infect young rabbits.

Etiology and Classification

Eimeria Species in Rabbits

Eleven Eimeria species are recognized in domestic rabbits (Oryctolagus cuniculus). These species are host-specific and monoxenous (single host life cycle). The species vary greatly in pathogenicity and target organ.

Hepatic Coccidiosis

Intestinal Coccidiosis Species

Life Cycle

All Eimeria species have a monoxenous (single host) direct life cycle. No intermediate hosts or vectors are required.

• Oocyst ingestion: Rabbit ingests sporulated oocysts via fecal-oral route from contaminated food, water, or bedding
• Excystation: Oocysts release sporozoites in the duodenum
• Migration: For E. stiedae: sporozoites penetrate duodenal mucosa and migrate via lymphatics or bloodstream to the liver within 12 hours. For intestinal species: sporozoites penetrate intestinal epithelium
• Schizogony (asexual reproduction): Multiple generations of schizonts produce merozoites in epithelial cells
• Gametogony (sexual reproduction): Formation of macrogametes (female) and microgametes (male)
• Oocyst formation: Fertilization produces unsporulated oocysts
• Environmental sporulation: Oocysts passed in feces sporulate in 1-4 days under favorable conditions (moist, cool, oxygen-rich)

Prepatent Periods

Epidemiology and Risk Factors

Prevalence

Prevalence varies widely: 41.9-87.4% in some studies. Overall infection rate can reach 44.2-70% in domestic rabbits depending on management and region. Wild rabbits often harbor coccidia their entire lives without disease.

Age Susceptibility

Most critical age: 4-16 weeks (recently weaned rabbits)

• Suckling rabbits less than 16 days old are NOT susceptible to intestinal coccidiosis
• 5-6 week old rabbits (just after weaning) are most susceptible
• Adult rabbits (greater than 4 months) rarely develop clinical disease but can be asymptomatic carriers
• Hepatic coccidiosis primarily affects young weanling rabbits

Risk Factors

• Poor hygiene: Fecal contamination of food, water, and bedding
• Overcrowding: Enhanced transmission when rabbits are housed in large groups
• Stress: Weaning, transport, environmental changes
• Immunosuppression: Any age if immune compromised
• High infective oocyst dose: Dose-dependent clinical disease (as few as 100 oocysts can cause infection in experimental studies)
• Breeding colonies: Most common in intensive production settings
• Seasonality: Peak intensity late spring to summer (more susceptible juveniles present)

Pathophysiology

Hepatic Coccidiosis (E. stiedae)

After sporozoites reach the liver, they invade bile duct epithelial cells. Schizogony and gametogony occur within these cells, leading to:

• Papillary hyperplasia of bile duct epithelium
• Bile duct dilation and ectasia
• Periportal fibrosis (in chronic cases)
• Lymphoplasmacytic infiltrates
• Hepatomegaly with characteristic white-yellow linear lesions
• Gallbladder distention (occasionally)
• Bile stasis and obstruction

Intestinal Coccidiosis

Pathologic changes vary by species but commonly include:

• Villous atrophy in small intestine
• Enterocyte destruction
• Mucosal necrosis and ulceration
• Edema and hemorrhage in colon and cecum
• Mixed inflammatory infiltrate (leukocytes)
• Hyperperistalsis (can lead to intussusception)

Clinical Signs

Clinical presentation ranges from subclinical infection (common in adults) to acute, fatal disease (in young, heavily infected rabbits).

Diagnosis

Fecal Examination

Gold standard for diagnosis: Detection of oocysts on fecal flotation or fecal smears

• Fecal flotation technique: Uses saturated salt or sugar solution to float oocysts
• Sporulation required: To differentiate between some intestinal species, oocysts must be sporulated (takes 3 days)
• Morphology assessment: Oocysts identified by size, shape, wall characteristics, micropyle presence, and residual body

Key Oocyst Morphological Features

Hematology and Biochemistry

Imaging

Ultrasonography findings in hepatic coccidiosis:

• Hepatomegaly
• Diffusely heterogeneous liver parenchyma
• Multiple poorly defined hyperechoic regions
• Dilated bile ducts (hyperechoic)
• Dilated gallbladder

Necropsy and Histopathology

Hepatic Coccidiosis Gross Findings

• Hepatomegaly - enlarged, firm liver
• Linear, raised white-yellow to gray lesions on liver surface and cut surface (PATHOGNOMONIC)
• Distended gallbladder containing bile
• Dilated bile ducts filled with green bile and debris
• Miliary hepatic abscesses (in acute cases)
• Ascites (abdominal effusion)
• Icterus (jaundice) of tissues

Hepatic Coccidiosis Microscopic Findings (PATHOGNOMONIC)

• Marked periportal fibrosis
• Bile duct hyperplasia (papillary hyperplasia of epithelium)
• Bile duct ectasia (dilation)
• Intraluminal developmental stages - schizonts, macrogametes, microgametes, and oocysts within bile duct epithelium
• Lymphoplasmacytic periportal infiltrate

Intestinal Coccidiosis Gross/Microscopic Findings

• Fluid intestinal contents (watery diarrhea)
• Colon and cecum congestion and edema
• Villous atrophy
• Mucosal ulceration and necrosis
• Intraluminal organisms in intestinal mucosa
• Leukocytic infiltrates

Differential Diagnoses

Treatment

Therapeutic Goals

• Eliminate or slow multiplication of protozoa
• Allow natural immunity to develop
• Provide supportive care
• Reduce environmental contamination

Anticoccidial Drugs

Supportive Care

• Fluid therapy: Correct dehydration over 12-24 hours (SC, IV, or IO route). Monitor blood pressure in collapsed rabbits
• Nutritional support: Syringe feeding or nasogastric tube. Critical Care or other high-fiber commercial products
• Prokinetics: Metoclopramide 0.5-1 mg/kg q6-8h PO or SC; Cisapride 0.5-1 mg/kg q6-8h PO
• Gastroprotectants: Ranitidine 2-5 mg/kg q12h PO to reduce gastric ulceration risk
• Analgesia: If needed for patient comfort

Prevention and Control

Prevention is the best approach given the ubiquity of coccidia and difficulty of eliminating environmental contamination.

Management Strategies

• Hygiene: Frequent cleaning of cages, feeders, and water containers. Remove feces DAILY before oocysts sporulate (takes 1-4 days)
• Bedding: Change frequently and keep dry. Wet bedding favors oocyst sporulation
• Food hygiene: Avoid fecal contamination of food. Use hay racks rather than floor feeding
• Separate young rabbits: Keep rabbits less than 4 months old out of contaminated areas
• Control mechanical vectors: Flies, vermin can spread oocysts
• Quarantine new arrivals: Test before introducing to colony
• Cull infected does: Stop breeding from known infected animals

Environmental Decontamination

Oocysts are extremely resistant and can survive for years under moist, cool conditions.

• Heat: 140°F (60°C) for 60 minutes OR 176°F (80°C) for 15 minutes renders approximately 80% of oocysts incapable of sporulation. Note: E. irresidua is more resistant
• Depopulation: In severe outbreaks, total depopulation, thorough cleaning, and restocking may be necessary

Vaccination

Precocious line vaccines are available in some regions:

• Live attenuated vaccines using shortened life cycle strains
• Immunogenic but not pathogenic at correct doses
• Can be sprayed into nesting boxes for entire litters
• Effective in commercial production settings
• Trivalent vaccines have been developed

Prophylactic Medication

In commercial operations, coccidiostats (sulfonamides, robenidine) may be added to feed prophylactically. However, drug resistance is increasingly seen in intensive production farms. Prophylaxis should be initiated before weaning since disease primarily affects 5-6 week old rabbits.

Prognosis

Zoonotic Potential and Public Health

Eimeria species found in rabbits are SPECIES-SPECIFIC and NOT zoonotic. They do NOT infect humans. Rabbit coccidiosis poses NO public health risk.